{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:37:23Z","timestamp":1789537043622,"version":"build-2803163510"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"MBSTU Research Cell"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00253-022-11988-x","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T10:03:13Z","timestamp":1653472993000},"page":"4091-4114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus"],"prefix":"10.1007","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-2918","authenticated-orcid":false,"given":"K. M. Kaderi","family":"Kibria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Omar","family":"Faruque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Shaid bin","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedayet","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafi","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojnu","family":"Miah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani Ali","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"11988_CR1","doi-asserted-by":"publisher","first-page":"2683286","DOI":"10.1155\/2020\/2683286","volume":"2020","author":"MI Abdelmageed","year":"2020","unstructured":"Abdelmageed MI, Abdelmoneim AH, Mustafa MI, Elfadol NM, Murshed NS, Shantier SW, Makhawi AM (2020) Design of a multiepitope-based peptide vaccine against the E protein of human COVID-19: an immunoinformatics approach. Biomed Res Int 2020:2683286. https:\/\/doi.org\/10.1155\/2020\/2683286","journal-title":"Biomed Res Int"},{"issue":"3","key":"11988_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/v12030254","volume":"12","author":"SF Ahmed","year":"2020","unstructured":"Ahmed SF, Quadeer AA, McKay MR (2020) Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses 12(3):254","journal-title":"Viruses"},{"key":"11988_CR3","doi-asserted-by":"publisher","unstructured":"Bappy SS, Sultana S, Adhikari J, Mahmud S, Khan MA, Kibria KMK, Rahman MM, Shibly AZ (2020) Extensive immunoinformatics study for the prediction of novel peptide-based epitope vaccine with docking confirmation against envelope protein of Chikungunya virus: a computational biology approach. J Biomol Struct Dyn 39(4):1139\u20131154. \u00a0https:\/\/doi.org\/10.1080\/07391102.2020.1726815","DOI":"10.1080\/07391102.2020.1726815"},{"issue":"153","key":"11988_CR4","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1186\/1471-2105-7-153","volume":"7","author":"HH Bui","year":"2006","unstructured":"Bui HH, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A (2006) Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics 7(153):1471\u20132105. https:\/\/doi.org\/10.1186\/1471-2105-7-153","journal-title":"BMC Bioinformatics"},{"issue":"7841","key":"11988_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/d41586-021-00031-0","volume":"589","author":"E Callaway","year":"2021","unstructured":"Callaway E (2021) Could new COVID variants undermine vaccines? Labs Scramble Find out Nat 589(7841):177\u2013178. https:\/\/doi.org\/10.1038\/d41586-021-00031-0","journal-title":"Labs Scramble Find out Nat"},{"key":"11988_CR6","unstructured":"Carl Zimmer JC, Sui-Lee Wee and Matthew Kristoffersen (2022) The New York Times Coronavirus Vaccine Tracker. Retrieved on 11 March 2022. https:\/\/www.nytimes.com\/interactive\/2020\/science\/coronavirus-vaccine-tracker.html"},{"issue":"16","key":"11988_CR7","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jcc.20290","volume":"26","author":"DA Case","year":"2005","unstructured":"Case DA, Cheatham TE 3rd, Darden T, Gohlke H, Luo R, Merz KM Jr, Onufriev A, Simmerling C, Wang B, Woods RJ (2005) The Amber biomolecular simulation programs. J Comput Chem 26(16):1668\u20131688. https:\/\/doi.org\/10.1002\/jcc.20290","journal-title":"J Comput Chem"},{"key":"11988_CR8","unstructured":"CDC (2020) CDC Reports first known employee with COVID-19 infection. https:\/\/www.cdc.gov\/media\/releases\/2020\/s0316-cdc-employee-covid-19.html. Retrieved on 16 March 2020."},{"issue":"1","key":"11988_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","volume":"9","author":"JF-W Chan","year":"2020","unstructured":"Chan JF-W, Kok K-H, Zhu Z, Chu H, To KK-W, Yuan S, Yuen K-Y (2020) Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 9(1):221\u2013236","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"11988_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41591-021-01294-w","volume":"27","author":"RE Chen","year":"2021","unstructured":"Chen RE, Zhang X, Case JB, Winkler ES, Liu Y, VanBlargan LA, Liu J, Errico JM, Xie X, Suryadevara N, Gilchuk P, Zost SJ, Tahan S, Droit L, Turner JS, Kim W, Schmitz AJ, Thapa M, Wang D, Boon ACM, Presti RM, O\u2019Halloran JA, Kim AHJ, Deepak P, Pinto D, Fremont DH, Crowe JE Jr, Corti D, Virgin HW, Ellebedy AH, Shi PY, Diamond MS (2021) Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med 27(4):717\u2013726. https:\/\/doi.org\/10.1038\/s41591-021-01294-w","journal-title":"Nat Med"},{"key":"11988_CR11","unstructured":"contributors W (2021) SARS-CoV-2 Omicron variant Wikipedia. Wikipedia, The Free Encyclopedia 1057450268"},{"issue":"1","key":"11988_CR12","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1186\/s12879-019-4571-5","volume":"19","author":"RM Dawood","year":"2019","unstructured":"Dawood RM, Moustafa RI, Abdelhafez TH, El-Shenawy R, El-Abd Y, El Din NGB, Dubuisson J, El Awady MK (2019) A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice. BMC Infect Dis 19(1):932","journal-title":"BMC Infect Dis"},{"key":"11988_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-0-387-79208-8_3","volume":"2","author":"AS De Groot","year":"2008","unstructured":"De Groot AS, Moise L, McMurry JA, Martin W (2008) Epitope-based immunome-derived vaccines: a strategy for improved design and safety. Clin App Immun 2:39\u201369. https:\/\/doi.org\/10.1007\/978-0-387-79208-8_3","journal-title":"Clin App Immun"},{"key":"11988_CR14","doi-asserted-by":"publisher","unstructured":"Deming D, Sheahan T, Heise M, Yount B, Davis N, Sims A, Suthar M, Harkema J, Whitmore A, Pickles R (2006) Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants. PLoS Med 3(12):e525. https:\/\/doi.org\/10.1371\/journal.pmed.0030525","DOI":"10.1371\/journal.pmed.0030525"},{"issue":"19","key":"11988_CR15","doi-asserted-by":"publisher","first-page":"194703","DOI":"10.1063\/1.4983163","volume":"146","author":"D Dimova","year":"2017","unstructured":"Dimova D, Pisov S, Panchev N, Nedyalkova M, Madurga S, Proykova A (2017) Insight into electric field-induced rupture mechanism of water-in-toluene emulsion films from a model system. J Chem Phys 146(19):194703. https:\/\/doi.org\/10.1063\/1.4983163","journal-title":"J Chem Phys"},{"issue":"3","key":"11988_CR16","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1128\/jvi.55.3.836-839.1985","volume":"55","author":"EA Emini","year":"1985","unstructured":"Emini EA, Hughes JV, Perlow DS, Boger J (1985) Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 55(3):836\u2013839","journal-title":"J Virol"},{"issue":"1","key":"11988_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.virusres.2007.01.021","volume":"133","author":"L Enjuanes","year":"2008","unstructured":"Enjuanes L, DeDiego ML, \u00c1lvarez E, Deming D, Sheahan T, Baric R (2008) Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease. Virus Res 133(1):45\u201362","journal-title":"Virus Res"},{"issue":"12","key":"11988_CR18","doi-asserted-by":"publisher","first-page":"v12121357","DOI":"10.3390\/v12121357","volume":"12","author":"B Flehmig","year":"2020","unstructured":"Flehmig B, Schindler M, Ruetalo N, Businger R, Bayer M, Haage A, Kirchner T, Klingel K, Normann A, Pridzun L, Tougianidou D, Ranke MB (2020) Persisting neutralizing activity to SARS-CoV-2 over months in sera of COVID-19 patients. Viruses 12(12):v12121357. https:\/\/doi.org\/10.3390\/v12121357","journal-title":"Viruses"},{"key":"11988_CR19","unstructured":"Forbes (2020) Can you get coronavirus twice? How long are you immune after COVID-19? https:\/\/www.forbes.com\/sites\/brucelee\/2020\/03\/15\/can-you-get-infected-by-coronavirus-twice-how-does-covid-19-immunity-work\/#4ffe1df35c0f. Retrieved on Mar 15, 2020"},{"issue":"2","key":"11988_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/v12020135","volume":"12","author":"LE Gralinski","year":"2020","unstructured":"Gralinski LE, Menachery VD (2020) Return of the coronavirus: 2019-nCoV. Viruses 12(2):135","journal-title":"Viruses"},{"issue":"1","key":"11988_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.chom.2020.11.007","volume":"29","author":"AJ Greaney","year":"2021","unstructured":"Greaney AJ, Starr TN, Gilchuk P, Zost SJ, Binshtein E, Loes AN, Hilton SK, Huddleston J, Eguia R, Crawford KHD, Dingens AS, Nargi RS, Sutton RE, Suryadevara N, Rothlauf PW, Liu Z, Whelan SPJ, Carnahan RH, Crowe JE Jr, Bloom JD (2021) Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe 29(1):44-57 e9. https:\/\/doi.org\/10.1016\/j.chom.2020.11.007","journal-title":"Cell Host Microbe"},{"key":"11988_CR22","doi-asserted-by":"publisher","unstructured":"Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, Liu L, Shan H, Lei C-L, Hui DS (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708\u20131720. https:\/\/doi.org\/10.1056\/NEJMoa2002032","DOI":"10.1056\/NEJMoa2002032"},{"key":"11988_CR23","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.4049\/jimmunol.174.8.4908","volume":"174","author":"Y He","year":"2005","unstructured":"He Y, Lu H, Siddiqui P, Zhou Y, Jiang S (2005) Receptor-binding domain of SARS coronavirus spike protein contains multiple conformational-dependant epitopes that induce highly potent neutralizing antibodies. J Immunol 174:4908\u20134915","journal-title":"J Immunol"},{"key":"11988_CR24","doi-asserted-by":"publisher","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. cell 181(2):271\u2013280. e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","DOI":"10.1016\/j.cell.2020.02.052"},{"issue":"2","key":"11988_CR25","doi-asserted-by":"publisher","first-page":"nu10020203","DOI":"10.3390\/nu10020203","volume":"10","author":"H Hug","year":"2018","unstructured":"Hug H, Mohajeri MH, La Fata G (2018) Toll-like receptors: regulators of the immune response in the human gut. Nutrients 10(2):nu10020203. https:\/\/doi.org\/10.3390\/nu10020203","journal-title":"Nutrients"},{"key":"11988_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.compbiolchem.2019.03.004","volume":"80","author":"MJ Islam","year":"2019","unstructured":"Islam MJ, Parves MR, Mahmud S, Tithi FA, Reza MA (2019) Assessment of structurally and functionally high-risk nsSNPs impacts on human bone morphogenetic protein receptor type IA (BMPR1A) by computational approach. Comput Biol Chem 80:31\u201345. https:\/\/doi.org\/10.1016\/j.compbiolchem.2019.03.004","journal-title":"Comput Biol Chem"},{"issue":"12","key":"11988_CR27","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s13205-020-02544-3","volume":"10","author":"MSB Islam","year":"2020","unstructured":"Islam MSB, Miah M, Hossain ME, Kibria KMK (2020) A conserved multi-epitope-based vaccine designed by targeting hemagglutinin protein of highly pathogenic avian H5 influenza viruses. 3 Biotech 10(12):546. https:\/\/doi.org\/10.1007\/s13205-020-02544-3","journal-title":"3 Biotech"},{"issue":"7","key":"11988_CR28","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3201\/eid1107.050219","volume":"11","author":"S Jiang","year":"2005","unstructured":"Jiang S, He Y, Liu S (2005) SARS vaccine development. Emerg Infect Dis 11(7):1016","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"11988_CR29","doi-asserted-by":"publisher","first-page":"10895","DOI":"10.1038\/s41598-020-67749-110","volume":"10","author":"T Kar","year":"2020","unstructured":"Kar T, Narsaria U, Basak S, Deb D, Castiglione F, Mueller DM, Srivastava AP (2020) A candidate multi-epitope vaccine against SARS-CoV-2. Sci Rep 10(1):10895. https:\/\/doi.org\/10.1038\/s41598-020-67749-110","journal-title":"Sci Rep"},{"key":"11988_CR30","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/BF01195768","volume":"72","author":"PA Karplus","year":"1985","unstructured":"Karplus PA, Schulz GE (1985) Prediction of chain flexibility in proteins. Naturwissenschaften 72:212\u2013213","journal-title":"Naturwissenschaften"},{"issue":"7853","key":"11988_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41586-021-03291-y","volume":"592","author":"SA Kemp","year":"2021","unstructured":"Kemp SA, Collier DA, Datir RP, Ferreira I, Gayed S, Jahun A, Hosmillo M, Rees-Spear C, Mlcochova P, Lumb IU, Roberts DJ, Chandra A, Temperton N, Sharrocks K, Blane E, Modis Y, Leigh KE, Briggs JAG, van Gils MJ, Smith KGC, Bradley JR, Smith C, Doffinger R, Ceron-Gutierrez L, Barcenas-Morales G, Pollock DD, Goldstein RA, Smielewska A, Skittrall JP, Gouliouris T, Goodfellow IG, Gkrania-Klotsas E, Illingworth CJR, McCoy LE, Gupta RK (2021) SARS-CoV-2 evolution during treatment of chronic infection. Nature 592(7853):277\u2013282. https:\/\/doi.org\/10.1038\/s41586-021-03291-y","journal-title":"Nature"},{"issue":"1\u20132","key":"11988_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0014-5793(90)80535-Q","volume":"276","author":"AS Kolaskar","year":"1990","unstructured":"Kolaskar AS, Tongaonkar PC (1990) A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276(1\u20132):172\u20134","journal-title":"FEBS Lett"},{"key":"11988_CR33","unstructured":"Krieger E, Elmar GV, Spronk C (2013) YASARA\u2013yet another scientific artificial reality application.\u00a0http:\/\/www.yasara.org\/"},{"issue":"4","key":"11988_CR34","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jmgm.2006.02.009","volume":"25","author":"E Krieger","year":"2006","unstructured":"Krieger E, Nielsen JE, Spronk CA, Vriend G (2006) Fast empirical pKa prediction by Ewald summation. J Mol Graph Model 25(4):481\u20136. https:\/\/doi.org\/10.1016\/j.jmgm.2006.02.009","journal-title":"J Mol Graph Model"},{"issue":"13","key":"11988_CR35","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/jcc.23899","volume":"36","author":"E Krieger","year":"2015","unstructured":"Krieger E, Vriend G (2015) New ways to boost molecular dynamics simulations. J Comput Chem 36(13):996\u20131007. https:\/\/doi.org\/10.1002\/jcc.23899","journal-title":"J Comput Chem"},{"issue":"4","key":"11988_CR36","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.chom.2021.03.008","volume":"29","author":"A Kuzmina","year":"2021","unstructured":"Kuzmina A, Khalaila Y, Voloshin O, Keren-Naus A, Boehm-Cohen L, Raviv Y, Shemer-Avni Y, Rosenberg E, Taube R (2021) SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera. Cell Host Microbe 29(4):522-528 e2. https:\/\/doi.org\/10.1016\/j.chom.2021.03.008","journal-title":"Cell Host Microbe"},{"key":"11988_CR37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/1471-2105-8-424","volume":"8","author":"MV Larsen","year":"2007","unstructured":"Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, Nielsen M (2007) Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics 8:424. https:\/\/doi.org\/10.1186\/1471-2105-8-424","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"11988_CR38","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/BF00228148","volume":"8","author":"RA Laskowski","year":"1996","unstructured":"Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8(4):477\u2013486","journal-title":"J Biomol NMR"},{"key":"11988_CR39","doi-asserted-by":"publisher","unstructured":"Letko MC, Munster V (2020) Functional assessment of cell entry and receptor usage for lineage B \u03b2-coronaviruses, including 2019-nCoV. Nature microbiol 5(4):562\u2013569. https:\/\/doi.org\/10.1038\/s41564-020-0688-y","DOI":"10.1038\/s41564-020-0688-y"},{"key":"11988_CR40","doi-asserted-by":"publisher","DOI":"10.1101\/2021.08.25.457692","author":"H Liu","year":"2021","unstructured":"Liu H, Wei P, Zhang Q, Aviszus K, Linderberger J, Yang J, Liu J, Chen Z, Waheed H, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G (2021) The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines. BioRxiv. https:\/\/doi.org\/10.1101\/2021.08.25.457692","journal-title":"BioRxiv"},{"issue":"8","key":"11988_CR41","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1086\/656315","volume":"202","author":"J Liu","year":"2010","unstructured":"Liu J, Sun Y, Qi J, Chu F, Wu H, Gao F, Li T, Yan J, Gao GF (2010) The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes. J Infect Dis 202(8):1171\u20131180","journal-title":"J Infect Dis"},{"issue":"10224","key":"11988_CR42","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 395(10224):565\u2013574","journal-title":"The Lancet"},{"issue":"20","key":"11988_CR43","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","volume":"384","author":"SA Madhi","year":"2021","unstructured":"Madhi SA, Baillie V, Cutland CL, Voysey M, Koen AL, Fairlie L, Padayachee SD, Dheda K, Barnabas SL, Bhorat QE, Briner C, Kwatra G, Ahmed K, Aley P, Bhikha S, Bhiman JN, Bhorat AE, du Plessis J, Esmail A, Groenewald M, Horne E, Hwa SH, Jose A, Lambe T, Laubscher M, Malahleha M, Masenya M, Masilela M, McKenzie S, Molapo K, Moultrie A, Oelofse S, Patel F, Pillay S, Rhead S, Rodel H, Rossouw L, Taoushanis C, Tegally H, Thombrayil A, van Eck S, Wibmer CK, Durham NM, Kelly EJ, Villafana TL, Gilbert S, Pollard AJ, de Oliveira T, Moore PL, Sigal A, Izu A (2021) Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant. N Engl J Med 384(20):1885\u20131898. https:\/\/doi.org\/10.1056\/NEJMoa2102214","journal-title":"N Engl J Med"},{"issue":"1","key":"11988_CR44","first-page":"1","volume":"29","author":"S Mahmoodi","year":"2017","unstructured":"Mahmoodi S, Nezafat N, Sarmadi S, Zarghami N, Ghasemi Y (2017) Expression and purification of a novel multi-epitope peptide vaccine for breast cancer immunotherapy. Minerva Biotecnologica 29(1):1\u20137","journal-title":"Minerva Biotecnologica"},{"issue":"14","key":"11988_CR45","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1080\/07391102.2019.1680440","volume":"38","author":"S Mahmud","year":"2019","unstructured":"Mahmud S, Parves MR, Riza YM, Sujon KM, Ray S, Tithi FA, Zaoti ZF, Alam S, Absar N (2019) Exploring the potent inhibitors and binding modes of phospholipase A2 through in silico investigation. J Biomol Struct Dyn 38(14):4221\u20134231. https:\/\/doi.org\/10.1080\/07391102.2019.1680440","journal-title":"J Biomol Struct Dyn"},{"key":"11988_CR46","doi-asserted-by":"crossref","unstructured":"Malik YS, Kumar P, Ansari MI, Hemida MG, El Zowalaty ME, Abdel-Moneim AS, Ganesh B, Salajegheh S, Natesan S, Sircar S (2021) SARS-CoV-2 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development. Front Mol Biosci 8:607886.\u00a0https:\/\/doi.org\/10.3389\/fmolb.2021.607886","DOI":"10.3389\/fmolb.2021.607886"},{"issue":"46","key":"11988_CR47","doi-asserted-by":"publisher","first-page":"6471","DOI":"10.1016\/j.vaccine.2009.06.018","volume":"27","author":"L Moise","year":"2009","unstructured":"Moise L, McMurry JA, Buus S, Frey S, Martin WD, De Groot AS (2009) In silico-accelerated identification of conserved and immunogenic variola\/vaccinia T-cell epitopes. Vaccine 27(46):6471\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2009.06.018","journal-title":"Vaccine"},{"key":"11988_CR48","doi-asserted-by":"publisher","first-page":"100546","DOI":"10.1016\/j.imu.2021.100546","volume":"23","author":"M Munia","year":"2021","unstructured":"Munia M, Mahmud S, Mohasin M, Kibria KMK (2021) In silico design of an epitope-based vaccine against choline binding protein A of Streptococcus pneumoniae. Inform Med Unlocked 23:100546. https:\/\/doi.org\/10.1016\/j.imu.2021.100546","journal-title":"Inform Med Unlocked"},{"issue":"19","key":"11988_CR49","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1021\/bi00367a013","volume":"25","author":"JM Parker","year":"1986","unstructured":"Parker JM, Guo D, Hodges RS (1986) New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 25(19):5425\u20135432","journal-title":"Biochemistry"},{"issue":"9\u201310","key":"11988_CR50","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1016\/j.micinf.2006.05.008","volume":"8","author":"H Peng","year":"2006","unstructured":"Peng H, Yang LT, Li J, Lu ZQ, Wang LY, Koup RA, Bailer RT, Wu CY (2006) Human memory T cell responses to SARS-CoV E protein. Microbes Infect 8(9\u201310):2424\u201331. https:\/\/doi.org\/10.1016\/j.micinf.2006.05.008","journal-title":"Microbes Infect"},{"issue":"4","key":"11988_CR51","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","volume":"183","author":"L Piccoli","year":"2020","unstructured":"Piccoli L, Park YJ, Tortorici MA, Czudnochowski N, Walls AC, Beltramello M, Silacci-Fregni C, Pinto D, Rosen LE, Bowen JE, Acton OJ, Jaconi S, Guarino B, Minola A, Zatta F, Sprugasci N, Bassi J, Peter A, De Marco A, Nix JC, Mele F, Jovic S, Rodriguez BF, Gupta SV, Jin F, Piumatti G, Lo Presti G, Pellanda AF, Biggiogero M, Tarkowski M, Pizzuto MS, Cameroni E, Havenar-Daughton C, Smithey M, Hong D, Lepori V, Albanese E, Ceschi A, Bernasconi E, Elzi L, Ferrari P, Garzoni C, Riva A, Snell G, Sallusto F, Fink K, Virgin HW, Lanzavecchia A, Corti D, Veesler D (2020) Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell 183(4):1024\u2013104221. https:\/\/doi.org\/10.1016\/j.cell.2020.09.037","journal-title":"Cell"},{"key":"11988_CR52","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/1471-2105-9-514","volume":"9","author":"J Ponomarenko","year":"2008","unstructured":"Ponomarenko J, Bui HH, Li W, Fusseder N, Bourne PE, Sette A, Peters B (2008) ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics 9:514. https:\/\/doi.org\/10.1186\/1471-2105-9-514","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"11988_CR53","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nrd2224","volume":"6","author":"AW Purcell","year":"2007","unstructured":"Purcell AW, McCluskey J, Rossjohn J (2007) More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discovery 6(5):404\u2013414","journal-title":"Nat Rev Drug Discovery"},{"key":"11988_CR54","unstructured":"Rambaut A, Loman N, Pybus O, Barclay W, Barrett J, Carabelli A, Connor T, Peacock T, Robertson DL, Volz E (2021) Preliminary genomic characterisation of an emergent SARSCoV-2 lineage in the UK defined by a novel set of spike mutations. COVID-19 Genomics Consortium UK (CoG-UK). https:\/\/virological.org\/t\/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-definedby-a-novel-set-of-spike-mutations\/563"},{"issue":"7","key":"11988_CR55","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1128\/JVI.03566-14","volume":"89","author":"JA Regla-Nava","year":"2015","unstructured":"Regla-Nava JA, Nieto-Torres JL, Jimenez-Guarde\u00f1o JM, Fernandez-Delgado R, Fett C, Casta\u00f1o-Rodr\u00edguez C, Perlman S, Enjuanes L, DeDiego ML (2015) Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates. J Virol 89(7):3870\u20133887","journal-title":"J Virol"},{"key":"11988_CR56","unstructured":"Reuters ( 2020) Coronavirus incubation could be as long as 27 days, Chinese provincial government says. Reuters, Feb. 22, 2020.\u00a0https:\/\/www.reuters.com\/article\/us-china-health-incubation-idUSKCN20G06W. Retrieved on 21 March, 2020"},{"issue":"7830","key":"11988_CR57","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","volume":"586","author":"U Sahin","year":"2020","unstructured":"Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, Baum A, Pascal K, Quandt J, Maurus D, Brachtendorf S, Lorks V, Sikorski J, Hilker R, Becker D, Eller AK, Grutzner J, Boesler C, Rosenbaum C, Kuhnle MC, Luxemburger U, Kemmer-Bruck A, Langer D, Bexon M, Bolte S, Kariko K, Palanche T, Fischer B, Schultz A, Shi PY, Fontes-Garfias C, Perez JL, Swanson KA, Loschko J, Scully IL, Cutler M, Kalina W, Kyratsous CA, Cooper D, Dormitzer PR, Jansen KU, Tureci O (2020) COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature 586(7830):594\u2013599. https:\/\/doi.org\/10.1038\/s41586-020-2814-7","journal-title":"Nature"},{"issue":"3","key":"11988_CR58","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/prot.340230306","volume":"23","author":"A Sali","year":"1995","unstructured":"Sali A, Potterton L, Yuan F, van Vlijmen H, Karplus M (1995) Evaluation of comparative protein modeling by MODELLER. Proteins 23(3):318\u2013326. https:\/\/doi.org\/10.1002\/prot.340230306","journal-title":"Proteins"},{"issue":"28","key":"11988_CR59","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1016\/j.vaccine.2014.04.026","volume":"32","author":"C Serna","year":"2014","unstructured":"Serna C, Lara JA, Rodrigues SP, Marques AF, Almeida IC, Maldonado RA (2014) A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease. Vaccine 32(28):3525\u201332. https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.026","journal-title":"Vaccine"},{"issue":"1","key":"11988_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-020-0170-0","volume":"5","author":"W Shang","year":"2020","unstructured":"Shang W, Yang Y, Rao Y, Rao X (2020) The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines. Npj Vaccines 5(1):1\u20133","journal-title":"Npj Vaccines"},{"key":"11988_CR61","doi-asserted-by":"publisher","DOI":"10.1101\/2020.12.21.20248640","author":"H Tegally","year":"2020","unstructured":"Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, Doolabh D, Pillay S, San EJ, Msomi N, Mlisana K, Gottberg AV, Walaza S, Allam M, Ismail A, Mohale T, Glass AJ, Engelbrecht S, Zyl GV, Preiser W, Petruccione F, Sigal A, Hardie D, Marais G, Hsiao M, Korsman S, Davies M, Tyers L, Mudau I, York D, Maslo C, Goedhals D, Abrahams S, Laguda-Akingba O, Alisoltani-Dehkordi A, Godzik A, Wibmer CK, Sewell BT, Louren\u00e7o J, Alcantara LCJ, Pond SLK, Weaver S, Martin D, Lessells RJ, Bhiman JN, Williamson C, OT D (2020) Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. MedRxiv. https:\/\/doi.org\/10.1101\/2020.12.21.20248640","journal-title":"MedRxiv"},{"key":"11988_CR62","unstructured":"TRACKER CV (2022) Vector State Research Center of Virology and Biotechnology: EpiVacCorona. Retrieved on 11 March 2022. https:\/\/covid19.trackvaccines.org\/vaccines\/32\/"},{"key":"11988_CR63","doi-asserted-by":"publisher","first-page":"105129","DOI":"10.1016\/j.meegid.2021.105129","volume":"96","author":"H Ullah","year":"2021","unstructured":"Ullah H, Mahmud S, Hossain MJ, Islam MSB, Kibria KMK (2021) Immunoinformatic identification of the epitope-based vaccine candidates from Maltoporin, FepA and OmpW of Shigella Spp, with molecular docking confirmation. Infect Genet Evol 96:105129. https:\/\/doi.org\/10.1016\/j.meegid.2021.105129","journal-title":"Infect Genet Evol"},{"key":"11988_CR64","doi-asserted-by":"publisher","unstructured":"Vakili B, Nezafat N, Zare B, Erfani N, Akbari M, Ghasemi Y, Rahbar MR, Hatam GR (2019) A new multi-epitope peptide vaccine induces immune responses and protection against Leishmania infantum in BALB\/c mice. Med microbiol and immunol 209(1):69\u201379. https:\/\/doi.org\/10.1007\/s00430-019-00640-7","DOI":"10.1007\/s00430-019-00640-7"},{"issue":"6","key":"11988_CR65","doi-asserted-by":"publisher","first-page":"317","DOI":"10.14740\/jocmr4518","volume":"13","author":"D Vasireddy","year":"2021","unstructured":"Vasireddy D, Vanaparthy R, Mohan G, Malayala SV, Atluri P (2021) Review of COVID-19 variants and COVID-19 vaccine efficacy: what the clinician should know? J Clin Med Res 13(6):317\u2013325. https:\/\/doi.org\/10.14740\/jocmr4518","journal-title":"J Clin Med Res"},{"key":"11988_CR66","doi-asserted-by":"crossref","unstructured":"Wan Y, Shang J, Graham R, Baric RS, Li F (2020) Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J virol 94(7):e00127\u201320. https:\/\/doi.org\/10.1128\/JVI.00127-20","DOI":"10.1128\/JVI.00127-20"},{"key":"11988_CR67","doi-asserted-by":"publisher","DOI":"10.1101\/2021a.01.25.428137","author":"P Wang","year":"2021","unstructured":"Wang P, Nair MS, Liu L, Iketani S, Luo Y, Guo Y, Wang M, Yu J, Zhang B, Kwong PD, Graham BS, Mascola JR, Chang JY, Yin MT, Sobieszczyk M, Kyratsous CA, Shapiro L, Sheng Z, Huang Y, Ho DD (2021) Increased resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 to antibody neutralization. BioRxiv. https:\/\/doi.org\/10.1101\/2021a.01.25.428137","journal-title":"BioRxiv"},{"key":"11988_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2021b.05.006","author":"R Wang","year":"2021","unstructured":"Wang R, Chen J, Gao K, Wei GW (2021) Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries. Genomics. https:\/\/doi.org\/10.1016\/j.ygeno.2021b.05.006","journal-title":"Genomics"},{"issue":"13","key":"11988_CR69","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1093\/bioinformatics\/bth195bth195[pii]","volume":"20","author":"JJ Ward","year":"2004","unstructured":"Ward JJ, McGuffin LJ, Bryson K, Buxton BF, Jones DT (2004) The DISOPRED server for the prediction of protein disorder. Bioinformatics 20(13):2138\u20132139. https:\/\/doi.org\/10.1093\/bioinformatics\/bth195bth195[pii]","journal-title":"Bioinformatics"},{"key":"11988_CR70","unstructured":"WHO (2021) Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern"},{"key":"11988_CR71","unstructured":"WHO (2022) Status of COVID-19 Vaccines within WHO EUL\/PQ evaluation process. World Health Organization (WHO). Retrieved on 11 March 2022. https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/documents\/Status_COVID_VAX_02March2022.pdf"},{"issue":"4","key":"11988_CR72","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","volume":"27","author":"CK Wibmer","year":"2021","unstructured":"Wibmer CK, Ayres F, Hermanus T, Madzivhandila M, Kgagudi P, Oosthuysen B, Lambson BE, de Oliveira T, Vermeulen M, van der Berg K, Rossouw T, Boswell M, Ueckermann V, Meiring S, von Gottberg A, Cohen C, Morris L, Bhiman JN, Moore PL (2021) SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat Med 27(4):622\u2013625. https:\/\/doi.org\/10.1038\/s41591-021-01285-x","journal-title":"Nat Med"},{"key":"11988_CR73","doi-asserted-by":"publisher","unstructured":"Wiederstein M, Sippl MJ (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35(Web Server issue):W407\u201310. https:\/\/doi.org\/10.1093\/nar\/gkm290","DOI":"10.1093\/nar\/gkm290"},{"key":"11988_CR74","doi-asserted-by":"publisher","first-page":"m4857","DOI":"10.1136\/bmj.m4857","volume":"371","author":"J Wise","year":"2020","unstructured":"Wise J (2020) Covid-19: new coronavirus variant is identified in UK. BMJ 371:m4857. https:\/\/doi.org\/10.1136\/bmj.m4857","journal-title":"BMJ"},{"key":"11988_CR75","doi-asserted-by":"publisher","unstructured":"Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao Z W, Tian J H, Pei Y Y, Yuan M L, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ (2020) A new coronavirus associated with human respiratory disease in China. Nature 579(7798):265\u2013269. https:\/\/doi.org\/10.1038\/s41586-020-2008-3","DOI":"10.1038\/s41586-020-2008-3"},{"key":"11988_CR76","doi-asserted-by":"publisher","DOI":"10.1101\/2021.01.25.427948","author":"K Wu","year":"2021","unstructured":"Wu K, Werner AP, Moliva JI, Koch M, Choi A, Stewart-Jones GBE, Bennett H, Boyoglu-Barnum S, Shi W, Graham BS, Carfi A, Corbett KS, Seder RA, Edwards DK (2021) mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants. BioRxiv. https:\/\/doi.org\/10.1101\/2021.01.25.427948","journal-title":"BioRxiv"},{"key":"11988_CR77","doi-asserted-by":"publisher","DOI":"10.1101\/2021.01.07.425740","author":"X Xie","year":"2021","unstructured":"Xie X, Zou J, Fontes-Garfias CR, Xia H, Swanson KA, Cutler M, Cooper D, Menachery VD, Weaver S, Dormitzer PR, Shi P (2021) Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera. BioRxiv. https:\/\/doi.org\/10.1101\/2021.01.07.425740","journal-title":"BioRxiv"},{"issue":"1","key":"11988_CR78","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nmeth.3213","volume":"12","author":"J Yang","year":"2015","unstructured":"Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y (2015) The I-TASSER Suite: protein structure and function prediction. Nat Methods 12(1):7\u20138. https:\/\/doi.org\/10.1038\/nmeth.3213","journal-title":"Nat Methods"},{"issue":"6982","key":"11988_CR79","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature02463","volume":"428","author":"Z-y Yang","year":"2004","unstructured":"Yang Z-y, Kong W-p, Huang Y, Roberts A, Murphy BR, Subbarao K, Nabel GJ (2004) A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 428(6982):561\u2013564","journal-title":"Nature"},{"key":"11988_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202008319","author":"T Ye","year":"2020","unstructured":"Ye T, Zhong Z, Garcia-Sastre A, Schotsaert M, De Geest BG (2020) Current status of COVID-19 (pre)clinical vaccine development. Angew Chem Int Ed Engl. https:\/\/doi.org\/10.1002\/anie.202008319","journal-title":"Angew Chem Int Ed Engl"},{"key":"11988_CR81","doi-asserted-by":"publisher","unstructured":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273. https:\/\/doi.org\/10.1038\/s41586-020-2012-7","DOI":"10.1038\/s41586-020-2012-7"},{"issue":"36","key":"11988_CR82","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.1016\/j.vaccine.2009.05.009","volume":"27","author":"W-Y Zhou","year":"2009","unstructured":"Zhou W-Y, Shi Y, Wu C, Zhang W-J, Mao X-H, Guo G, Li H-X, Zou Q-M (2009) Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB\/c mice model. Vaccine 27(36):5013\u20135019","journal-title":"Vaccine"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-022-11988-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-022-11988-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-022-11988-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T04:11:08Z","timestamp":1655266268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-022-11988-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":82,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["11988"],"URL":"https:\/\/doi.org\/10.1007\/s00253-022-11988-x","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"15 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by Ethical review committee of Mawlana Bhashani Science and Technology University. The ethical approval number: MBSTU\/ ERC\/ ECC\/157\/03\/2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}